Photodynamic therapy: Palliation and endoscopic technique in cholangiocarcinoma

被引:12
作者
Richter, James A. [1 ]
Kahaleh, Michel [1 ]
机构
[1] Univ Virginia Hlth Syst, Charlottesville, VA 22908 USA
关键词
Cholangiocarcinoma; Cholestasis; Jaundice; Neoplasia; Palliation; Photodynamic therapy; Photofrin;
D O I
10.4253/wjge.v2.i11.357
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Cholangiocarcinoma is the primary malignancy arising from the biliary epithelium. The disease is marked by jaundice, cholestasis, and cholangitis. Over 50 percent of patients present with advanced stage disease, precluding curative surgical resection as an option of treatment. Prognosis is poor, and survival has been limited even after biliary decompression. Palliative management has become the standard of care for unresectable disease and has evolved to include an endoscopic approach. Photodynamic therapy (PDT) consists of administration of a photosensitizer followed by local irradiation with laser therapy. Several studies conducted in Europe and the United States have shown a marked improvement in the symptoms of cholestasis, survival, and quality of life. This article summarizes the published experience regarding PDT for cholangiocarcinoma and the steps required to administer this therapy safely. (C) 2010 Baishideng. All rights reserved.
引用
收藏
页码:357 / 361
页数:5
相关论文
共 70 条
[1]   Photodynamic therapy for pancreatic and biliary tract carcinoma [J].
Lakshmana Ayaru ;
Stephen G. Bown ;
Stephen P. Pereira .
International Journal of Gastrointestinal Cancer, 2005, 35 (1) :1-13
[2]   IMPROVEMENTS IN SURVIVAL BY AGGRESSIVE RESECTIONS OF HILAR CHOLANGIOCARCINOMA [J].
BAER, HU ;
STAIN, SC ;
DENNISON, AR ;
EGGERS, B ;
BLUMGART, LH .
ANNALS OF SURGERY, 1993, 217 (01) :20-27
[3]  
Baisden Joseph M, 2008, Gastrointest Cancer Res, V2, P219
[4]   Photodynarnic therapy: Standard of care for palliation of cholangiocarcinoma? [J].
Baron, Todd H. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2008, 6 (03) :266-267
[5]   Hepatic and extrahepatic malignancies in primary sclerosing cholangitis [J].
Bergquist, A ;
Ekbom, A ;
Olsson, R ;
Kornfeldt, D ;
Lööf, L ;
Danielsson, Å ;
Hultcrantz, R ;
Lindgren, S ;
Prytz, H ;
Sandberg-Gertzén, H ;
Almer, S ;
Granath, F ;
Broomé, U .
JOURNAL OF HEPATOLOGY, 2002, 36 (03) :321-327
[6]   Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis [J].
Bergquist, A ;
Broomé, U .
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2001, 15 (04) :643-656
[7]   Photodynamic therapy for advanced bile duct cancer:: Evidence for improved palliation and extended survival [J].
Berr, F ;
Wiedmann, M ;
Tannapfel, A ;
Halm, U ;
Kohlhaw, KR ;
Schmidt, F ;
Wittekind, C ;
Hauss, J ;
Mössner, J .
HEPATOLOGY, 2000, 31 (02) :291-298
[8]   Surgical treatment and outcomes in carcinoma of the extrahepatic bile ducts -: The University of Rochester experience [J].
Blom, D ;
Schwartz, SI .
ARCHIVES OF SURGERY, 2001, 136 (02) :209-214
[9]   Long-term outcome in patients with advanced hilar bile duct tumors undergoing palliative endoscopic or percutaneous drainage [J].
Born, P ;
Rösch, T ;
Brühl, T ;
Sandschin, W ;
Weigert, N ;
Ott, R ;
Frimberger, E ;
Allescher, HD ;
Hoffmann, W ;
Neuhaus, H ;
Classen, M .
ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2000, 38 (06) :483-489
[10]   A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in non-resectable cholangiocarcinoma [J].
Bowling, TE ;
Galbraith, SM ;
Hatfield, ARW ;
Solano, J ;
Spittle, MF .
GUT, 1996, 39 (06) :852-855